Project Grant HT94252410545
- The University of California, San Francisco (UCSF) has been awarded a $726,745 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will support a 3-year research project to investigate "DISSECTING RAS GAP SPECIFICITY IN THE PERIPHERAL NERVOUS SYSTEM". The research aims to advance the understanding of key cellular signaling mechanisms involved in the peripheral nervous system, with...
- This federal Project Grant award of $997,060 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of California, San Francisco (UCSF) to develop a new understanding of selective neuron vulnerability and neuroprotection in progressive multiple sclerosis. The award has a performance period from September 15, 2024 to September 14, 2027. As a leading academic medical center and research institution, UCSF will leverage...
- The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
- This $999,999.00 Project Grant was awarded on August 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF). The grant supports a 3-year research project focused on developing cell-free DNA epigenetic biomarkers for multiple sclerosis. As a prominent academic medical center, UCSF will leverage its expertise in neuroscience, biomedical research, and clinical translational...
- The University of California, San Francisco (UCSF) was awarded a $973,947 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Imaging Cardiac Metabolic Flux and Mitochondrial Function by Hyperpolarized 13C and CEST Metabolic Magnetic Resonance Imaging." The project will run from July 15, 2025 to July 14, 2029 and aims to develop innovative medical imaging techniques to investigate cardiac...
- This $993,283 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco on September 1, 2025. The grant will support a 2-year research project titled "Proteomic Determinants and Components of Progression in Multiple Sclerosis" to be conducted in San Francisco, CA. The project aims to advance biomedical research that can transform healthcare for military...
- The University of California, San Francisco (UCSF) was awarded a $1,195,789 Project Grant from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), to conduct research on the "Safety of Transcutaneous Electrical Stimulation Potentiating Recovery in Acute Spinal Cord Injury Syndromes (STEP-RAISE)". The grant period runs from July 1, 2025 to June 30, 2028. The research project aims to investigate innovative medical solutions for addressing...
- This $2,377,839 Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports evidence-based prediction of cardiovascular risk in immune-mediated inflammatory disease. The primary awardee is The Regents of the University of California, San Francisco (UCSF), a prominent academic medical research institution. The award period runs from June 1, 2025 to May 31, 2029, and the research will be conducted in San Francisco, CA. The...
- The U.S. Defense Health Agency awarded a $1,312,000.00 Project Grant to the Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective August 1, 2025 through July 31, 2029, supports research strategies to upregulate and image Nectin4 to enhance Nectin4-targeted therapies in bladder cancer. As a prominent academic medical center and research institution, UCSF will leverage its expertise in...
- The University of California, San Francisco (UCSF) has been awarded a $726,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year federal grant, with a period of performance from June 2024 to June 2027, will support research to elucidate the role of ERα RNA binding activity in breast cancer progression and drug-tolerant persister cells. As a leading academic medical center with extensive experience in federally...
The Regents of the University of California, San Francisco (UCSF) has been awarded a $499,985 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project titled "DIET, EXERCISE, AND INFLAMMATION IN EARLY-STAGE NEURONAL ALPHA-SYNUCLEIN DISEASE" to investigate novel approaches for treating neurodegenerative disorders relevant to military personnel and the broader population. As a leading academic medical research institution, UCSF will leverage its expertise in neuroscience, clinical research, and translational medicine to advance this critical area of study. The findings from this project are expected to inform the development of more effective interventions for early-stage neurological conditions characterized by alpha-synuclein pathology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $500.0k | 5/20/24 |